×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Lung-Map: A Future Clinical Trial with a Master Protocol Happening Now and the Value to Patients
Session Chair(s)
Stephen Smith, MA
Consultant, United States
This session will provide an overview of a future clinical trial design happening now: Lung-Map. We will include a description of the design, milestones attained, and observations about biostatistics, reduced patient burden, efficiencies, and increased chances of success. The value to patients is explored including aspects of this trial design that overcome traditional problems with clinical trial design.
Learning Objective : Discuss how the Lung-Map Trial consolidates into one trial what traditionally takes multiple trials to complete; Identify how the Lung-Map trial design for the Lung-Map trial creates efficiencies; Explain how the Lung-Map trial reduces patient burden; Describe how the Lung-Map trial increases the chances of success through more powerful statistical results.
Speaker(s)
LungMAP Trial Design and Value to Patients
Stephen Smith, MA
Consultant, United States
LungMAP Progress to Date and Next Steps
James Moon
Fred Hutchinson Cancer Research Center (FHCRC), United States
Biostatistics
Have an account?
Ways to register
Registration override should work.